The Foundation for Sarcoidosis Research (FSR) to provide $50,000 in Sarcoidosis Research Funding Exploring Environmental Causes of sarcoidosis and for Identifying Neurosarc Biomarkers
Retrieved on:
Thursday, November 24, 2022
Orangi Pilot Project, Patient, NIH Intramural Research Program, Critical care, Disease, University of Colorado Boulder Computer Science Department, Environment, Biopsy, Quality of life, Diagnosis, MBA, FSR, Inflammation, Biomarker, Neurosarcoidosis, University of Iowa, User experience, University of Colorado School of Medicine, Fungus, University, Sarcoidosis, Research, Internal, MD, Occupational medicine, Associate, HIV disease progression rates, Education, Medical imaging, Pharmaceutical industry, Medicine
CHICAGO, Nov. 23, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the funding for two new pilot projects in sarcoidosis.
Key Points:
- CHICAGO, Nov. 23, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the funding for two new pilot projects in sarcoidosis.
- These research projects show great promise in advancing the understanding, diagnosis, and management of sarcoidosis.
- FSR is dedicated to accelerating sarcoidosis research through fellowships, small grants, large grants, and disease specific grants to advance sarcoidosis research and advance care for those living with sarcoidosis.
- The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and to improving care for sarcoidosis patients through research, education, and support.